Proposals for Engaging Patients and Healthcare Professionals in Risk Minimisation from an Analysis of Stakeholder Input to the EU Valproate Assessment Using the Novel Analysing Stakeholder Safety Engagement Tool

Drug Safety

Risk minimisation measures (RMMs) are a key issue for better care and Bahri and colleagues’ plan to enhance the dialogue between regulators, health care professionals (HCPs) and patients at the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) with a Stakeholder Safety Engagement Tool is welcome [1]

Source : Drug Safety Alain Braillon; Marine Martin